Also from this source


You just read:

CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel's Assuta Medical Center to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids

News provided by

Therapix Biosciences

Jul 11, 2017, 08:00 ET